Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

Amedisys (AMED) delivered earnings and revenue surprises of 10.62% and 0%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for ...

AMED and the union local that represents the organization’s workers have agreed to a new contract. The deal provides a pay increase totaling 21.6% over three years for the American Federation of State ...

James Arnold Robbins, age 77 of Glades Community, passed away on April 20, 2025 at 10:00 p.m., pronounced by Amedisys Hospice ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) ...

As part of Amedisys Hospice’s We Honor Veterans Program, Patricia Brewer gives Ned Melancon a Navy pin during his 100th ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...

UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s ...

The United States Justice Department’s lawsuit to block UnitedHealth Group’s (UHG’s) $3.3 billion acquisition of Amedisys ...

A federal judge in Maryland ordered the Justice Department and UnitedHealth Group to begin mediation on Aug. 18.

The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will ...